Thoracic radiotherapy may enhance the survival of patients with low‐risk advanced lung adenocarcinoma based on protein biomarkers

Documenti analoghi

• Thoracic radiotherapy timing and prognostic factors in elderly patients with limited‐stage small cell lung cancer
  di: Huan Zhao, et al.
  Pubblicazione: (2024)
• Clinical application of high‐LET radiotherapy combined with immunotherapy in malignant tumors
  di: Kexin Meng, et al.
  Pubblicazione: (2024)
• Clinical outcomes of thoracic radiotherapy in combination with chemoimmunotherapy in elderly patients with extensive‐stage small cell lung cancer
  di: Jinmin Han, et al.
  Pubblicazione: (2026)
• One‐year follow‐up after fractionated ultra‐high‐dose‐rate FLASH radiotherapy in patient with extramammary Paget disease of the scrotum
  di: Hui Luo, et al.
  Pubblicazione: (2025)
• Comments on “On the significance of peak dose in normal tissue toxicity in spatially fractionated radiotherapy: The case of proton minibeam radiation therapy”
  di: Zhaoning Wang, et al.
  Pubblicazione: (2025)